NDC 80425-0228-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0228
- Requested NDC
- 80425-0228-01
- Package NDCs from labels
- 80425-0228-1, 80425-0228-2, 80425-0228-3, 80425-0228-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0228-1 | Ondansetron | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 6 | |
| 80425-0228-1 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 6 | |
| 80425-0228-2 | Ondansetron | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 6 | |
| 80425-0228-2 | Ondansetron | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 6 | |
| 80425-0228-3 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0228 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, 5 package rows | 20240224_f1a0b9ee-c1d2-7818-e053-2995a90a3e96.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0228-1 | EA - Each | 80425-0228 | fa25cf8c-1b2c-4fa0-a25f-e449a12dc055 | 1 | 2023-04-07 |
| 80425-0228-2 | EA - Each | 80425-0228 | be69a6f8-bffd-4c20-b029-ee37c66a28e3 | 1 | 2023-06-06 |
| 80425-0228-3 | EA - Each | 80425-0228 | d416152b-61d5-41ee-b10c-d0ebec5d3c51 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Asclemed USA, Inc. | 269c920c-643a-4eea-9bf9-b1f008915db9 | 2026-08-28 | Warnings, Adverse reactions | ANDA090469 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | f175a336-433b-7ab2-e053-2995a90ad5ca | 2026-08-26 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | c0d827d0-333f-4187-ac75-9dc7d34b6169 | 2026-08-11 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals, Inc. | 66ac9c17-bea7-4f8d-8a27-a1e0f9e65945 | 2026-08-07 | Warnings, Adverse reactions | ANDA090469 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals Inc. | 7975d78c-9bb6-467a-9c2d-ea15bde7af5c | 2026-08-07 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals, Inc. | 70b48280-ef74-472b-abc3-128962bfcb05 | 2026-08-07 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 3c4cda2f-13d9-42c5-b449-77deb06c8de5 | 2026-08-03 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 5a81a39b-051b-414e-a6b0-d844de4e9ab4 | 2026-07-29 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 02ddd5f5-76d3-4f1c-9af3-d39e05a19c29 | 2026-07-29 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | 41366a20-0727-0446-e063-6294a90a957f | 2026-07-28 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | HAWAII REPACK, INC. | b76c5cc9-f1ca-428b-8989-36a66802b650 | 2026-07-17 | Warnings, Adverse reactions | ANDA090469 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 18063a64-a4c0-4bad-911b-00df5c7bb65d | 2026-07-07 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 9c3ad9c1-474e-4331-a017-09cec46702d8 | 2026-07-07 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 77397df5-5a4f-41b2-98bc-f817a1e497fc | 2026-07-02 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 822404ad-af08-4c62-ae38-7d9819e86079 | 2026-07-01 | Warnings, Adverse reactions | ANDA090469 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | 3207cf04-73b7-24ce-e054-00144ff8d46c | 2026-06-30 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc | 4575d288-be0c-f6c3-e063-6294a90af708 | 2026-06-29 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 3c34ca82-9705-4784-be7c-8b50351d14fc | 2026-06-12 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals Inc. | e87a5803-e872-43f7-8a15-79aa236e8c07 | 2026-06-11 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | BluePoint Laboratories | ed1132ec-c2cd-4646-b69d-26663bb937a4 | 2026-06-10 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.